Photo Credit: Bharat Biotech
New Delhi, May 16: A study by Peer-Review, a peer-reviewed publication, Clinical Infectious Diseases, reported that covacin showed protection against the new Covid-19 variant. According to a new study, India Biotech has neutralized activity against emerging forms of the covacaine coronavirus. Read more: Sputnik light may soon arrive in India after Sputnik V, find out how effective single dose vaccine corona is
A study published by Clinical Infectious Diseases found that vaccines with covacin were recognized in India and the United Kingdom, as opposed to the large emerging strains B1616 and B117 that were tested, respectively.
The study was conducted in collaboration with the National Institute of Virology and the Indian Council of Medical Research.